• Issue

    Liver International: Volume 37, Issue 3

    313-470
    March 2017
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

ISSUE INFORMATION

Free Access

Issue Information

  • Pages: 313-315
  • First Published: 27 February 2017

REVIEWS

Free Access

Current challenges and future directions for liver transplantation

Pierluigi Toniutto,  Alberto Zanetto,  Alberto Ferrarese,  Patrizia Burra, 
  • Pages: 317-327
  • First Published: 16 September 2016
Free Access

Potential use of metabolic breath tests to assess liver disease and prognosis: has the time arrived for routine use in the clinic?

R. Todd Stravitz,  Yaron Ilan, 
  • Pages: 328-336
  • First Published: 08 October 2016

DEBATES IN HEPATOLOGY

Liver transplantation for patients with alcoholic hepatitis

Florent Artru,  Alexandre Louvet,  Philippe Mathurin, 
  • Pages: 337-339
  • First Published: 27 February 2017

Liver transplantation for severe alcoholic hepatitis–The CON view

James Y. Y. Fung, 
  • Pages: 340-342
  • First Published: 27 February 2017

Liver transplantation for severe alcoholic hepatitis– The PRO view

Michael R. Lucey, 
  • Pages: 343-344
  • First Published: 27 February 2017

VIRAL HEPATITIS

The cost impact of outreach testing and treatment for hepatitis C in an urban Drug Treatment Unit

Nowlan Selvapatt,  Thomas Ward,  Lorna Harrison,  Jody Lombardini,  Mark Thursz,  Phil McEwan,  Ashley Brown, 
  • Pages: 345-353
  • First Published: 27 August 2016

Identification of novel OCT4 genetic variant associated with the risk of chronic hepatitis B in a Korean population

Joong-Gon Shin,  Hyun Sub Cheong,  Kwanghyun Lee,  Bong-Gun Ju,  Jeong-Hoon Lee,  Su Jong Yu,  Jung-Hwan Yoon,  Jae Youn Cheong,  Sung Won Cho,  Neung Hwa Park,  Suhg Namgoong,  Lyoung Hyo Kim,  Yoon Jun Kim,  Hyoung Doo Shin, 
  • Pages: 354-361
  • First Published: 06 September 2016

A combination of different diagnostic tools allows identification of inactive hepatitis B virus carriers at a single time point evaluation

Sergio Maimone,  Gaia Caccamo,  Giovanni Squadrito,  Angela Alibrandi,  Francesca Saffioti,  Rosaria Spinella,  Giuseppina Raffa,  Teresa Pollicino,  Giovanni Raimondo, 
  • Pages: 362-368
  • First Published: 05 October 2016

Direct antiviral agent treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers fibrosis-4 score and aspartate aminotransferase-platelet ratio index

Jacqueline A. Bachofner,  Piero V. Valli,  Arne Kröger,  Irina Bergamin,  Patrizia Künzler,  Adriana Baserga,  Dominique Braun,  Burkhardt Seifert,  Anja Moncsek,  Jan Fehr,  David Semela,  Lorenzo Magenta,  Beat Müllhaupt,  Benedetta Terziroli Beretta-Piccoli,  Joachim C. Mertens, 
  • Pages: 369-376
  • First Published: 28 September 2016

LIVER FAILURE, CIRRHOSIS AND ITS COMPLICATIONS

Plasma biomarkers to study mechanisms of liver injury in patients with hypoxic hepatitis

James L. Weemhoff,  Benjamin L. Woolbright,  Rosalind E. Jenkins,  Mitchell R. McGill,  Matthew R. Sharpe,  Jody C. Olson,  Daniel J. Antoine,  Steven C. Curry,  Hartmut Jaeschke, 
  • Pages: 377-384
  • First Published: 18 July 2016

Clinical course and short-term mortality of cirrhotic patients with infections other than spontaneous bacterial peritonitis

Javier Fernández,  Juan Acevedo,  Verónica Prado,  Mario Mercado,  Miriam Castro,  Marco Pavesi,  Mireya Arteaga,  Lydia Sastre,  Adria Juanola,  Pere Ginès,  Vicente Arroyo, 
  • Pages: 385-395
  • First Published: 25 August 2016

Shear-wave elastography of the liver and spleen identifies clinically significant portal hypertension: A prospective multicentre study

Christian Jansen,  Christopher Bogs,  Wim Verlinden,  Maja Thiele,  Philipp Möller,  Jan Görtzen,  Jennifer Lehmann,  Thomas Vanwolleghem,  Luisa Vonghia,  Michael Praktiknjo,  Johannes Chang,  Aleksander Krag,  Christian P. Strassburg,  Sven Francque,  Jonel Trebicka, 
  • Pages: 396-405
  • First Published: 29 August 2016

Midodrine and tolvaptan in patients with cirrhosis and refractory or recurrent ascites: a randomised pilot study

Nitish Rai,  Baljinder Singh,  Akash Singh,  Rajesh Vijayvergiya,  Navneet Sharma,  Ashish Bhalla,  Virendra Singh, 
  • Pages: 406-414
  • First Published: 10 September 2016

CANCER

Characteristics of hepatocellular carcinoma in Egyptian patients with primary Budd-Chiari syndrome

Mohammad Sakr,  Sara M. Abdelhakam,  Hany Dabbous,  Amr Hamed,  Zeinab Hefny,  Waleed Abdelmoaty,  Mohamed Shaker,  Mohamed El-Gharib,  Ahmed Eldorry, 
  • Pages: 415-422
  • First Published: 10 August 2016

Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma

Anna Pecorelli,  Barbara Lenzi,  Annagiulia Gramenzi,  Francesca Garuti,  Fabio Farinati,  Edoardo G. Giannini,  Francesca Ciccarese,  Fabio Piscaglia,  Gian Lodovico Rapaccini,  Maria Di Marco,  Eugenio Caturelli,  Marco Zoli,  Franco Borzio,  Rodolfo Sacco,  Giuseppe Cabibbo,  Martina Felder,  Filomena Morisco,  Antonio Gasbarrini,  Gianluca Svegliati Baroni,  Francesco G. Foschi,  Elisabetta Biasini,  Alberto Masotto,  Roberto Virdone,  Mauro Bernardi,  Franco Trevisani, for the Italian LiverCancer (ITA.LI.CA) group , 
  • Pages: 423-433
  • First Published: 27 August 2016

Metformin confers risk reduction for developing hepatocellular carcinoma recurrence after liver resection

Kun-Ming Chan,  Chang-Fu Kuo,  Jun-Te Hsu,  Meng-Jiun Chiou,  Yu-Chao Wang,  Tsung-Han Wu,  Chen-Fang Lee,  Ting-Jung Wu,  Hong-Shiue Chou,  Wei-Chen Lee, 
  • Pages: 434-441
  • First Published: 24 October 2016

AUTOIMMUNE AND CHOLESTATIC LIVER DISEASE

Epidemiology and outcomes of primary sclerosing cholangitis with and without inflammatory bowel disease in an Australian cohort

Ken Liu,  Ruoxi Wang,  Viraj Kariyawasam,  Mark Wells,  Simone I. Strasser,  Geoff McCaughan,  Crispin Corte,  Rupert W. Leong, 
  • Pages: 442-448
  • First Published: 28 November 2016

Concurrent extrahepatic autoimmunity in autoimmune hepatitis: implications for diagnosis, clinical course and long-term outcomes

Guan-Wee Wong,  Tian Yeong,  David Lawrence,  Andrew D. Yeoman,  Sumita Verma,  Michael A. Heneghan, 
  • Pages: 449-457
  • First Published: 19 August 2016

Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitis

Johannes R. Hov,  Kirsten M. Boberg,  Eli Taraldsrud,  Mette Vesterhus,  Maria Boyadzhieva,  Inger Camilla Solberg,  Erik Schrumpf,  Morten H. Vatn,  Benedicte A. Lie,  Øyvind Molberg,  Tom H. Karlsen, 
  • Pages: 458-465
  • First Published: 25 August 2016

LETTERS TO THE EDITOR

The association between diabetes mellitus and cirrhosis mortality

Yi-Bing Hu,  Xin-Yue Tang,  Rong-Quan Fu, 
  • Page: 466
  • First Published: 12 September 2016

Reponse to the association between diabetes mellitus and cirrhosis mortality

George Boon-Bee Goh,  An Pan,  Wan-Cheng Chow,  Jian-Min Yuan,  Woon-Puay Koh, 
  • Page: 467
  • First Published: 27 February 2017

Mushroom poisoning: an overlooked cause of acute liver injury in China

Jiawei Geng,  Zhengyu Cao,  Xiuying Ma,  Yingjie Shi,  Yi Wang,  Qiuwei Pan, 
  • Pages: 468-469
  • First Published: 10 December 2016

The forgotten place of radioembolization for the treatment of hepatocellular carcinoma with portal vein tumour thrombosis

Giovanni Battista Levi Sandri,  Quirino Lai,  Pierleone Lucatelli, 
  • Pages: 469-470
  • First Published: 06 November 2016